{"id":5350,"date":"2016-08-17T19:50:43","date_gmt":"2016-08-17T19:50:43","guid":{"rendered":"https:\/\/lmcca.wpengine.com\/?p=5350"},"modified":"2016-08-17T19:56:02","modified_gmt":"2016-08-17T19:56:02","slug":"sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes","status":"publish","type":"post","link":"https:\/\/www.lmc.ca\/zh\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/","title":{"rendered":"\u8d5b\u8bfa\u83f2\u7684 AdlyxinTM \u83b7\u5f97 FDA \u6279\u51c6\u7528\u4e8e\u6cbb\u7597\u6210\u4eba 2 \u578b\u7cd6\u5c3f\u75c5\u60a3\u8005"},"content":{"rendered":"<p><a href=\"http:\/\/en.sanofi.com\/\">\u8d5b\u8bfa\u83f2<\/a> \u4e8e7\u670828\u65e5\u5ba3\u5e03\uff0c\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u6279\u51c6\u4e86Adlyxin<sup>\u6709\u9650\u516c\u53f8<\/sup> \u5229\u897f\u62c9\u6765\uff08lixisenatide\uff09\uff0c\u4e00\u79cd\u6bcf\u65e5\u4e00\u6b21\u7684\u9910\u65f6GLP-1\u53d7\u4f53\u6fc0\u52a8\u5242\u6ce8\u5c04\u5242\uff0c\u7528\u4e8e\u996e\u98df\u548c\u8fd0\u52a8\u7684\u8f85\u52a9\u6cbb\u7597\uff0c\u9002\u7528\u4e8e2\u578b\u7cd6\u5c3f\u75c5\u6210\u5e74\u60a3\u8005\u3002.<\/p>\n<p><em>\u201cAdlyxin \u7684\u83b7\u6279\u91cd\u7533\u4e86\u6211\u4eec\u81f4\u529b\u4e8e\u89e3\u51b3\u7cd6\u5c3f\u75c5\u60a3\u8005\u5728\u8fbe\u5230\u548c\u7ef4\u6301\u4e2a\u4f53\u8840\u7cd6\uff08HbA1c\uff09\u76ee\u6807\u65f6\u9762\u4e34\u7684\u6311\u6218\u3002\u201d<\/em> \u8d5b\u8bfa\u83f2\u5168\u7403\u7cd6\u5c3f\u75c5\u4e0e\u5fc3\u8840\u7ba1\u4e1a\u52a1\u90e8\u95e8\u6267\u884c\u526f\u603b\u88c1\u517c\u8d1f\u8d23\u4eba Peter Guenter\n\u8868\u793a\uff1a\u201c\u6211\u4eec\u5bf9\u8fd9\u9879\u6279\u51c6\u611f\u5230\u9ad8\u5174\uff0c\u56e0\u4e3a\u5b83\u4e3a\u6211\u4eec\u63d0\u4f9b\u4e86\u7ee7\u7eed\u5e2e\u52a9\u672a\u5f97\u5230\u6709\u6548\u63a7\u5236\u7684\u63a5\u53d7\u57fa\u7840\u80f0\u5c9b\u7d20\u6cbb\u7597\u7684\u60a3\u8005\u7684\u673a\u4f1a\u3002\u201d.<\/p>\n<p>Adlyxin \u7684\u6279\u51c6<sup>\u6709\u9650\u516c\u53f8<\/sup> \u57fa\u4e8eFDA\u5bf9GetGoal\u4e34\u5e8a\u9879\u76ee\u7ed3\u679c\u548cELIXA\u8bd5\u9a8c\u7ed3\u679c\u7684\u5ba1\u67e5\uff0c\u8be5\u8bd5\u9a8c\u6210\u529f\u6ee1\u8db3\u4e86FDA\u5173\u4e8e\u8bc1\u660e\u5fc3\u8840\u7ba1\u5b89\u5168\u6027\u7684\u8981\u6c42\u3002GetGoal\u4e34\u5e8a\u9879\u76ee\u5305\u62ec13\u9879\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u6d89\u53ca\u5168\u74035000\u591a\u540d2\u578b\u7cd6\u5c3f\u75c5\u6210\u4eba\u60a3\u8005\uff0c\u8bc4\u4f30\u4e86\u5229\u897f\u90a3\u80bd\u57282\u578b\u7cd6\u5c3f\u75c5\u6210\u4eba\u60a3\u8005\u4e2d\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002GetGoal\u9879\u76ee\u7684\u6240\u6709\u7814\u7a76\u5747\u6210\u529f\u8fbe\u5230\u4e86\u964d\u4f4e\u7cd6\u5316\u8840\u7ea2\u86cb\u767d\uff08HbA1c\uff09\u7684\u4e3b\u8981\u7597\u6548\u7ec8\u70b9\u3002Adlyxin\u62a5\u544a\u4e2d\u6700\u5e38\u89c1\u7684\u4e0d\u826f\u4e8b\u4ef6\u5305\u62ec\u6076\u5fc3\u3001\u4f4e\u8840\u7cd6\u548c\u5455\u5410\u3002.<\/p>\n<p>Adlyxin \u5c06\u4ee5\u4e00\u6b21\u6027\u9884\u586b\u5145\u6ce8\u5c04\u7b14\u7684\u5f62\u5f0f\u63d0\u4f9b\uff0c\u5355\u5242\u91cf\u4e3a 20 \u5fae\u514b\u3002\u60a3\u8005\u8fd8\u5c06\u6536\u5230\u4e00\u652f\u5355\u5242\u91cf\u4e3a 10 \u5fae\u514b\u7684\u9884\u586b\u5145\u6ce8\u5c04\u7b14\uff0c\u5e94\u6bcf\u5929\u6ce8\u5c04\u4e00\u6b21\uff0c\u6301\u7eed 14 \u5929\u3002\u7b2c 15 \u5929\uff0c\u60a3\u8005\u5c06\u5242\u91cf\u589e\u52a0\u5230\u6bcf\u5929 20 \u5fae\u514b\uff0c\u6bcf\u5929\u6ce8\u5c04\u4e00\u6b21\u3002.<\/p>\n<p>\u5982\u9700\u67e5\u770b\u5168\u6587\uff0c\u8bf7\u70b9\u51fb<a href=\"http:\/\/www.europeanpharmaceuticalreview.com\/42672\/news\/industry-news\/adlyxin-sanofi-fda-approval-type-2-diabetes\/\"> \u8fd9\u91cc<\/a><\/p>\n<h3 style=\"text-align: center;\"><a href=\"https:\/\/www.lmc.ca\/zh\/\">LMC \u7cd6\u5c3f\u75c5\u4e0e\u5185\u5206\u6ccc\u79d1<\/a> \u5f88\u8363\u5e78\u53c2\u4e0e\u4e86\u8fd9\u4e9b\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u5e76\u6210\u4e3aAdlyxin\u6279\u51c6\u8fc7\u7a0b\u7684\u4e00\u90e8\u5206\u3002<sup>\u6709\u9650\u516c\u53f8<\/sup> \u5229\u897f\u62c9\u6765\u5728\u6211\u4eec\u7684\u52a0\u62ff\u5927\u8bca\u6240\u3002\u4e34\u5e8a\u7814\u7a76\u662f\u836f\u7269\u5ba1\u6279\u8fc7\u7a0b\u4e2d\u4e0d\u53ef\u6216\u7f3a\u7684\u4e00\u90e8\u5206\u2014\u2014\u5982\u679c\u6ca1\u6709\u50cf\u60a8\u8fd9\u6837\u7684\u4eba\uff0c\u8fd9\u4e9b\u836f\u7269\u5c06\u65e0\u6cd5\u83b7\u5f97\u6279\u51c6\uff0c\u751a\u81f3\u4e0d\u53ef\u80fd\u5b58\u5728\uff01<\/h3>\n<h3 style=\"text-align: center;\">\u611f\u8c22\u60a8\u4e3a\u7814\u7a76\u6240\u505a\u7684\u4e00\u5207\uff01<\/h3>\n<p>&nbsp;<\/p>\n<h3 style=\"text-align: center;\"><em>\u6709\u5174\u8da3\u53c2\u52a0\u672a\u6765\u7684 2 \u578b\u7cd6\u5c3f\u75c5\u7814\u7a76\u5417\uff1f<br \/>\n\u8bbf\u95ee <a href=\"http:\/\/www.improvinghealth.ca\">www.improvinghealth.ca\u00a0<\/a>\u4e86\u89e3\u66f4\u591a\u5173\u4e8e <a href=\"http:\/\/improvinghealth.ca\/studies\/\">\u6b63\u5728\u8fdb\u884c\u7684\u6d3b\u52a8<\/a> \u6211\u4eec\u6b63\u5728\u62db\u8058\uff01\u00a0<\/em><\/h3>","protected":false},"excerpt":{"rendered":"<p>Sanofi announced on July 28th that the U.S. Food and Drug Administration (FDA) approved AdlyxinTM (lixisenatide), a once-daily mealtime GLP-1 receptor agonist injection indicated as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes. \u201cThe approval of Adlyxin reaffirms our continued commitment to addressing the challenges faced by people [&hellip;]<\/p>\n","protected":false},"author":25,"featured_media":5352,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","two_page_speed":[],"footnotes":""},"categories":[163],"tags":[156,155,83,112,161,160,159,124,162,154,158,157],"class_list":["post-5350","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-adlyxin","tag-adlyxintm","tag-diabetes-research","tag-diabetes-specialists","tag-elixa-trial","tag-getgoal","tag-getgoal-clinical-program","tag-lmc-diabetes","tag-lmc-diabetes-endocrinology","tag-sanofi","tag-t2-diabetes","tag-type-2-diabetes"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sanofi receives FDA approval of AdlyxinTM for treatment of adults with Type 2 Diabetes - LMC Healthcare: Helping You Understand and Control your Diabetes<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lmc.ca\/zh\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sanofi receives FDA approval of AdlyxinTM for treatment of adults with Type 2 Diabetes - LMC Healthcare: Helping You Understand and Control your Diabetes\" \/>\n<meta property=\"og:description\" content=\"Sanofi announced on July 28th that the U.S. Food and Drug Administration (FDA) approved AdlyxinTM (lixisenatide), a once-daily mealtime GLP-1 receptor agonist injection indicated as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes. \u201cThe approval of Adlyxin reaffirms our continued commitment to addressing the challenges faced by people [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lmc.ca\/zh\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/\" \/>\n<meta property=\"og:site_name\" content=\"LMC Healthcare: Helping You Understand and Control your Diabetes\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LMCDiabetesandEndocrinology\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-08-17T19:50:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2016-08-17T19:56:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.lmc.ca\/wp-content\/uploads\/2016\/08\/iStock_000014930955Large.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1811\" \/>\n\t<meta property=\"og:image:height\" content=\"2714\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"LMC Healthcare\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@lmc_diabetes\" \/>\n<meta name=\"twitter:site\" content=\"@lmc_diabetes\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"LMC Healthcare\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/\"},\"author\":{\"name\":\"LMC Healthcare\",\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/#\\\/schema\\\/person\\\/0d459c76f19eec906969bebe87612783\"},\"headline\":\"Sanofi receives FDA approval of AdlyxinTM for treatment of adults with Type 2 Diabetes\",\"datePublished\":\"2016-08-17T19:50:43+00:00\",\"dateModified\":\"2016-08-17T19:56:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/\"},\"wordCount\":355,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.lmc.ca\\\/wp-content\\\/uploads\\\/2016\\\/08\\\/iStock_000014930955Large.jpg\",\"keywords\":[\"Adlyxin\",\"AdlyxinTM\",\"diabetes research\",\"diabetes specialists\",\"elixa trial\",\"getgoal\",\"getgoal clinical program\",\"lmc diabetes\",\"lmc diabetes &amp; endocrinology\",\"sanofi\",\"t2 diabetes\",\"type 2 diabetes\"],\"articleSection\":[\"News\"],\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/\",\"url\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/\",\"name\":\"Sanofi receives FDA approval of AdlyxinTM for treatment of adults with Type 2 Diabetes - LMC Healthcare: Helping You Understand and Control your Diabetes\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.lmc.ca\\\/wp-content\\\/uploads\\\/2016\\\/08\\\/iStock_000014930955Large.jpg\",\"datePublished\":\"2016-08-17T19:50:43+00:00\",\"dateModified\":\"2016-08-17T19:56:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/#\\\/schema\\\/person\\\/0d459c76f19eec906969bebe87612783\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.lmc.ca\\\/wp-content\\\/uploads\\\/2016\\\/08\\\/iStock_000014930955Large.jpg\",\"contentUrl\":\"https:\\\/\\\/www.lmc.ca\\\/wp-content\\\/uploads\\\/2016\\\/08\\\/iStock_000014930955Large.jpg\",\"width\":1811,\"height\":2714,\"caption\":\"SONY DSC\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/news\\\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.lmc.ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sanofi receives FDA approval of AdlyxinTM for treatment of adults with Type 2 Diabetes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/#website\",\"url\":\"https:\\\/\\\/www.lmc.ca\\\/\",\"name\":\"LMC Healthcare: Helping You Understand and Control your Diabetes\",\"description\":\"Consulting Design Engineers\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.lmc.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.lmc.ca\\\/#\\\/schema\\\/person\\\/0d459c76f19eec906969bebe87612783\",\"name\":\"LMC Healthcare\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/831e22d0d516971177882663c91de9cbcda2f3a549f3a2d9f98d385139c6e8f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/831e22d0d516971177882663c91de9cbcda2f3a549f3a2d9f98d385139c6e8f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/831e22d0d516971177882663c91de9cbcda2f3a549f3a2d9f98d385139c6e8f2?s=96&d=mm&r=g\",\"caption\":\"LMC Healthcare\"},\"url\":\"https:\\\/\\\/www.lmc.ca\\\/zh\\\/author\\\/andrea\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sanofi receives FDA approval of AdlyxinTM for treatment of adults with Type 2 Diabetes - LMC Healthcare: Helping You Understand and Control your Diabetes","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lmc.ca\/zh\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/","og_locale":"zh_CN","og_type":"article","og_title":"Sanofi receives FDA approval of AdlyxinTM for treatment of adults with Type 2 Diabetes - LMC Healthcare: Helping You Understand and Control your Diabetes","og_description":"Sanofi announced on July 28th that the U.S. Food and Drug Administration (FDA) approved AdlyxinTM (lixisenatide), a once-daily mealtime GLP-1 receptor agonist injection indicated as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes. \u201cThe approval of Adlyxin reaffirms our continued commitment to addressing the challenges faced by people [&hellip;]","og_url":"https:\/\/www.lmc.ca\/zh\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/","og_site_name":"LMC Healthcare: Helping You Understand and Control your Diabetes","article_publisher":"https:\/\/www.facebook.com\/LMCDiabetesandEndocrinology\/","article_published_time":"2016-08-17T19:50:43+00:00","article_modified_time":"2016-08-17T19:56:02+00:00","og_image":[{"width":1811,"height":2714,"url":"https:\/\/www.lmc.ca\/wp-content\/uploads\/2016\/08\/iStock_000014930955Large.jpg","type":"image\/jpeg"}],"author":"LMC Healthcare","twitter_card":"summary_large_image","twitter_creator":"@lmc_diabetes","twitter_site":"@lmc_diabetes","twitter_misc":{"Written by":"LMC Healthcare","Est. reading time":"2 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/#article","isPartOf":{"@id":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/"},"author":{"name":"LMC Healthcare","@id":"https:\/\/www.lmc.ca\/#\/schema\/person\/0d459c76f19eec906969bebe87612783"},"headline":"Sanofi receives FDA approval of AdlyxinTM for treatment of adults with Type 2 Diabetes","datePublished":"2016-08-17T19:50:43+00:00","dateModified":"2016-08-17T19:56:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/"},"wordCount":355,"commentCount":0,"image":{"@id":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lmc.ca\/wp-content\/uploads\/2016\/08\/iStock_000014930955Large.jpg","keywords":["Adlyxin","AdlyxinTM","diabetes research","diabetes specialists","elixa trial","getgoal","getgoal clinical program","lmc diabetes","lmc diabetes &amp; endocrinology","sanofi","t2 diabetes","type 2 diabetes"],"articleSection":["News"],"inLanguage":"zh-Hans","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/","url":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/","name":"Sanofi receives FDA approval of AdlyxinTM for treatment of adults with Type 2 Diabetes - LMC Healthcare: Helping You Understand and Control your Diabetes","isPartOf":{"@id":"https:\/\/www.lmc.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/#primaryimage"},"image":{"@id":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lmc.ca\/wp-content\/uploads\/2016\/08\/iStock_000014930955Large.jpg","datePublished":"2016-08-17T19:50:43+00:00","dateModified":"2016-08-17T19:56:02+00:00","author":{"@id":"https:\/\/www.lmc.ca\/#\/schema\/person\/0d459c76f19eec906969bebe87612783"},"breadcrumb":{"@id":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/#primaryimage","url":"https:\/\/www.lmc.ca\/wp-content\/uploads\/2016\/08\/iStock_000014930955Large.jpg","contentUrl":"https:\/\/www.lmc.ca\/wp-content\/uploads\/2016\/08\/iStock_000014930955Large.jpg","width":1811,"height":2714,"caption":"SONY DSC"},{"@type":"BreadcrumbList","@id":"https:\/\/www.lmc.ca\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.lmc.ca\/"},{"@type":"ListItem","position":2,"name":"Sanofi receives FDA approval of AdlyxinTM for treatment of adults with Type 2 Diabetes"}]},{"@type":"WebSite","@id":"https:\/\/www.lmc.ca\/#website","url":"https:\/\/www.lmc.ca\/","name":"LMC\u533b\u7597\u5065\u5eb7\uff1a\u5e2e\u52a9\u60a8\u4e86\u89e3\u548c\u7ba1\u7406\u7cd6\u5c3f\u75c5","description":"\u54a8\u8be2\u8bbe\u8ba1\u5de5\u7a0b\u5e08","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lmc.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Person","@id":"https:\/\/www.lmc.ca\/#\/schema\/person\/0d459c76f19eec906969bebe87612783","name":"LMC\u533b\u7597\u4fdd\u5065","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/secure.gravatar.com\/avatar\/831e22d0d516971177882663c91de9cbcda2f3a549f3a2d9f98d385139c6e8f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/831e22d0d516971177882663c91de9cbcda2f3a549f3a2d9f98d385139c6e8f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/831e22d0d516971177882663c91de9cbcda2f3a549f3a2d9f98d385139c6e8f2?s=96&d=mm&r=g","caption":"LMC Healthcare"},"url":"https:\/\/www.lmc.ca\/zh\/author\/andrea\/"}]}},"_links":{"self":[{"href":"https:\/\/www.lmc.ca\/zh\/wp-json\/wp\/v2\/posts\/5350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lmc.ca\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lmc.ca\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lmc.ca\/zh\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lmc.ca\/zh\/wp-json\/wp\/v2\/comments?post=5350"}],"version-history":[{"count":0,"href":"https:\/\/www.lmc.ca\/zh\/wp-json\/wp\/v2\/posts\/5350\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lmc.ca\/zh\/wp-json\/wp\/v2\/media\/5352"}],"wp:attachment":[{"href":"https:\/\/www.lmc.ca\/zh\/wp-json\/wp\/v2\/media?parent=5350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lmc.ca\/zh\/wp-json\/wp\/v2\/categories?post=5350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lmc.ca\/zh\/wp-json\/wp\/v2\/tags?post=5350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}